Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
Trading Ideas
Reiteration
Health Care
From
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Tickers
CYTK
NEWS
NVS
Tags
News
Large Cap
Health Care
From
Benzinga
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Tickers
CYTK
NEWS
NVS
Tags
News
why it's moving
Benzinga
From
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
Briefs
Benzinga
Movers
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
General
Expert Ideas
Briefs
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
LLY
GOOG
AI Generated
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
Short Ideas
Benzinga
Trading Ideas
From
Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
January 04, 2024
Tickers
NEWS
NVS
VYGR
Tags
VYGR
Small Cap
why it's moving
From
Benzinga
Big Players' Recent Trades in NVS Options
January 04, 2024
Tickers
NVS
Tags
BZI/UOA
Options
Benzinga
From
Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
Today's Market
NBIX
VYGR
From
InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
January 02, 2024
Tickers
NEWS
NVS
VYGR
Tags
General
Small Cap
Briefs
From
Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
Tickers
CING
NEWS
NVS
Tags
Market News
NVS
why it's moving
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
Today's Market
NASDAQ:CYTK,NYSE:BMY,NYSE:NVS,NASDAQ:AZN
BMY
From
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Tickers
AZN
LLY
NVS
Tags
AZN
LLY
NVS
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
Market News
NVS
CALT
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
Small Cap
General
Expert Ideas
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
BZI/SHORTHIST
Market News
NVS
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
Trading Ideas
Health Care
Equities
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
TSM
PSNY
LLY
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
News
Briefs
Large Cap
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
NVS
Market News
Eurasia
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
GILD
Market News
NVS
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
News
Large Cap
Briefs
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
Market News
NVS
BZI/SHORTHIST
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
Expert Ideas
Briefs
Biotech
From
Benzinga
Cabaletta Bio’s and Gracell’s stock falls sharply as FDA investigates risks of CAR-T therapy
November 28, 2023
Tickers
BMY
CABA
GILD
GRCL
Tags
GILD
NVS
CABA
From
MarketWatch
3 Healthcare Stocks to Pick Up Before the Year-End Rally
November 28, 2023
Tickers
BSX
NVS
UNH
Tags
BSX
Stocks to Buy
NVS
From
InvestorPlace
Novartis Outlines Pure-Play Strategy Progress After Generics Business Spin-Off
November 28, 2023
Tickers
NVS
Tags
Biotech
Earnings
Benzinga
From
Benzinga
Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On
November 16, 2023
Tickers
CVRX
JNJ
LEGN
NVS
Tags
JNJ
Recent Press Releases
LEGN
From
Motley Fool
Verve Therapeutics’ stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
November 13, 2023
Tickers
BEAM
LLY
NVS
SPX
Tags
BEAM
VERV
LLY
From
MarketWatch
< Previous
1
2
3
4
5
6
7
8
9
...
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.